Glenmark Pharmaceuticals will pay $25 million to settle a case with the US Department of Justice related to generic drug pricing. The settlement, announced late Wednesday, will be paid by Glenmark Pharmaceuticals Inc, USA, a subsidiary of the Mumbai-based company, in six installments over five years. The settlement amount will accrue interest at 4.25% per annum starting from May 28, 2024.
This…
Mankind Pharma Ltd, the fourth-largest pharmaceutical company in India, is gearing up to raise over ₹9,000 crore through a combination of non-convertible debentures (NCDs) and short-term commercial paper. This move is part of the company’s strategy to support its ₹13,630 crore acquisition of Bharat Serums and Vaccines Ltd (BSV), a deal first announced in late July.
The company anticipates an…
Shares of Marksans Pharma surged 16% to a record high of ₹217 in Wednesday’s trading on the BSE, driven by impressive financial results for the June 2024 quarter (Q1FY25). The stock hit an intra-day peak at ₹217 and was trading at ₹216.35, up 15% at 01:49 pm, outperforming the BSE Sensex, which rose just 0.24%.
Strong Q1 Performance
Marksans Pharma’s stock rallied following the…
Sun Pharmaceutical Industries Ltd’s new alopecia treatment, Leqselvi (Deuruxolitinib), recently approved by the US Food and Drug Administration (FDA), is encountering legal challenges that may delay its market debut. A motion for a preliminary injunction has been filed in a US court to block the drug’s launch, putting the company’s planned rollout on hold.
Due to these ongoing legal…
